5 ASX 200 Stocks for 2026

ASX 200 stocks provide a diverse mix of companies across sectors such as resources, healthcare, technology and infrastructure which creates massive opportunities for investors.

Investors in 2026 should focus on the following ASX 200 stocks with solid financials, clear growth pipelines and exposure to strong structural trends.

South32 Limited (ASX: S32)

South32 Limited (ASX: S32) stands out as one of the best ASX 200 stocks to buy in 2026 because it benefits from higher commodity prices and strong operations.

The company in the first half of FY26 reported profit after tax of US$464 million and underlying earnings of US$435 million. This reflects solid financial growth across its core segments.

A strong level of profitability was seen as underlying EBITDA reached US$1.107 billion while the operating margin stood at 28%.

Its balance sheet remains strong because net debt is only US$25 million while liquidity is supported by about US$1.7 billion in cash which allows flexibility for growth and shareholder returns.

Favourable commodity prices along with demand from electrification and disciplined cost control could support further earnings growth in 2026.

Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Limited (ASX: TLX) is now seen by many as one of the best ASX 200 stocks to buy in 2026 because it is expanding its radiopharmaceutical pipeline and growing its global presence.

The company has several late-stage assets in progress which include the TLX591-Tx prostate cancer therapy. Phase 3 data shows a favourable safety and tolerability profile and there are no new safety concerns.

Results from clinical trials show that tumours retain the treatment for longer periods and side effects remain manageable. This supports the commercial potential of its targeted oncology therapies.

One important update is the NDA resubmission to the US FDA for TLX101-Px which is a brain cancer imaging agent that has already received Fast Track and Orphan Drug designations.

The company in 2026 could see strong growth because of possible regulatory approvals global expansion and rising demand for precision oncology solutions which may help it stand out.

NEXTDC Limited (ASX: NXT)

NEXTDC Limited (ASX: NXT) is a fantastic pick among ASX 200 stocks to buy in 2026 because demand for data centres is rising fast due to AI cloud and hyperscale computing.

The company in first half FY26 reported strong financials as total revenue increased 13% to $231.8 million while net revenue reached $189.2 million which shows solid top line growth.

Underlying EBITDA reached $115.3 million which increased 9% because higher utilisation and operating leverage improved profitability as capacity expanded.

A 297MW forward order book along with expansion across Australia and Asia and higher AI related deployments are expected to translate into future revenue and earnings.

Strong demand trends large contracted capacity and faster revenue conversion together suggest that NEXTDC could see strong earnings growth in 2026 and benefit from the global data infrastructure boom.

Aristocrat Leisure Limited (ASX: ALL)

Aristocrat Leisure Limited (ASX: ALL)is now seen as one of the best ASX 200 stocks to buy in 2026 because of its strong global gaming portfolio and steady earnings growth across different segments.

The company in FY25 reported revenue of $6.3 billion which rose 11% while NPATA reached $1.55 billion which increased 12% and this shows solid operating performance along with benefits from scale.

Profitability stayed strong as EBITDA reached $2.63 billion and margins improved to 41.7% because the business benefited from operating leverage and careful cost control.

Management expects NPATA to grow in 2026 which is likely to come from digital expansion along with content scaling and strong demand across gaming markets which could make Aristocrat a long-term compounder.

APA Group (ASX: APA)

APA Group (ASX: APA) is a solid ASX 200 stock to buy in 2026 because it operates a stable energy infrastructure business with inflation linked revenues and offers a strong income profile with a current annual yield of 6.18%.

The company in 1H26 reported segment revenue of $1,412 million while underlying EBITDA rose by 7.6% to $1,092 million which shows resilient earnings performance.

EBITDA margins reached 77.3% which reflects very strong profitability because inflation linked contracts and disciplined cost control support margins.

Free cash flow stood at $556 million while more than 90% of revenue is tied to inflation which supports stable cash flows and provides strong visibility for consistent dividend distributions.

(Source: Company Reports)